GIMAP1 report

Query

Invalid input gene. Please select from the suggestions.

I. Expression across cell types

Cell ontologyData table

Name	Number of supported studies	Average coverage
natural killer cell	25 studies	24% ± 6%	Explore
endothelial cell	24 studies	29% ± 13%	Explore
CD4-positive, alpha-beta T cell	20 studies	28% ± 9%	Explore
CD8-positive, alpha-beta T cell	19 studies	28% ± 7%	Explore
endothelial cell of lymphatic vessel	14 studies	27% ± 10%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	14 studies	35% ± 11%	Explore
T cell	13 studies	24% ± 8%	Explore
regulatory T cell	13 studies	23% ± 5%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	12 studies	33% ± 11%	Explore
gamma-delta T cell	12 studies	22% ± 5%	Explore
capillary endothelial cell	11 studies	25% ± 6%	Explore
classical monocyte	10 studies	30% ± 12%	Explore
endothelial cell of artery	10 studies	32% ± 8%	Explore
mature NK T cell	9 studies	23% ± 7%	Explore
non-classical monocyte	9 studies	29% ± 9%	Explore
CD16-negative, CD56-bright natural killer cell, human	8 studies	22% ± 5%	Explore
vein endothelial cell	8 studies	22% ± 4%	Explore
endothelial cell of vascular tree	8 studies	25% ± 8%	Explore
CD16-positive, CD56-dim natural killer cell, human	7 studies	23% ± 5%	Explore
mucosal invariant T cell	7 studies	23% ± 6%	Explore
CD4-positive, alpha-beta memory T cell	7 studies	25% ± 3%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	28% ± 9%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	26% ± 9%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	28% ± 10%	Explore
macrophage	5 studies	24% ± 7%	Explore
T follicular helper cell	5 studies	25% ± 8%	Explore
exhausted T cell	4 studies	38% ± 12%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	31% ± 9%	Explore
CD4-positive helper T cell	3 studies	19% ± 2%	Explore
glomerular endothelial cell	3 studies	36% ± 6%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	34% ± 7%	Explore
innate lymphoid cell	3 studies	22% ± 8%	Explore
monocyte	3 studies	20% ± 5%	Explore

II. Expression across tissues

sc-RNAseq dataData table

Name	Number of supported studies	Average coverage
peripheral blood	10 studies	28% ± 8%	Explore

Bulk RNAseq dataData table

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
thymus	100%	1282.65	652 / 653	99%	6.32	599 / 605
breast	100%	1816.47	459 / 459	94%	4.35	1052 / 1118
kidney	98%	671.79	87 / 89	93%	8.00	837 / 901
prostate	95%	556.78	233 / 245	91%	2.66	457 / 502
lung	100%	2024.57	578 / 578	86%	3.32	993 / 1155
adrenal gland	91%	514.20	236 / 258	89%	3.76	204 / 230
uterus	100%	1190.62	170 / 170	78%	2.33	358 / 459
intestine	98%	889.67	946 / 966	73%	2.04	384 / 527
bladder	100%	788.10	21 / 21	69%	2.12	350 / 504
stomach	88%	473.79	317 / 359	78%	2.60	223 / 286
esophagus	92%	709.07	1333 / 1445	72%	1.90	131 / 183
brain	59%	228.47	1558 / 2642	99%	4.60	698 / 705
skin	64%	347.20	1156 / 1809	80%	4.16	379 / 472
pancreas	31%	97.12	101 / 328	93%	4.42	166 / 178
ovary	58%	289.45	105 / 180	65%	1.48	278 / 430
liver	35%	126.25	79 / 226	86%	2.59	350 / 406
adipose	100%	2004.25	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	15.63	29 / 29
spleen	100%	4854.54	241 / 241	0%	0	0 / 0
heart	97%	825.75	836 / 861	0%	0	0 / 0
peripheral blood	93%	1908.45	867 / 929	0%	0	0 / 0
tonsil	0%	0	0 / 0	87%	4.14	39 / 45
muscle	83%	347.08	667 / 803	0%	0	0 / 0
blood vessel	77%	538.52	1032 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	38%	0.96	30 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1